Filana Therapeutics, Inc.
MX ˙ BMV ˙ US14817C1071
SecurityMX:FLNA / Filana Therapeutics, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership41,324 shares
Latest Disclosed Value $ 69,838
Goldman Sachs Group Inc ownership in FLNA / Filana Therapeutics, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 41,324 shares of Filana Therapeutics, Inc. (MX:FLNA) valued at $69,838 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 32,989 shares of Filana Therapeutics, Inc.. This represents a change in shares of 25.27% during the quarter.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (FLNA) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:FLNA / Filana Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F FILANA THERAPEUTICS CMN 14817C107 41,324 8,335 25.27 70 6.15 0.0000
2026-02-10 2025-12-31 13F CASSAVA SCIENCES CMN 14817C107 32,989 -439,871 -93.02 65 -95.28 0.0000
2025-11-14 2025-09-30 13F CASSAVA SCIENCES CMN 14817C107 472,860 -140,283 -22.88 1,376 24.08 0.0002
2025-08-14 2025-06-30 13F CASSAVA SCIENCES CMN 14817C107 613,143 116,830 23.54 1,110 49.06 0.0002
2025-06-27 2025-03-31 13F/A-2 CASSAVA SCIENCES CMN 14817C107 496,313 217,404 77.95 744 13.07 0.0001
2025-05-16 2025-03-31 13F/A-1 CASSAVA SCIENCES CMN 14817C107 496,313 217,404 744 0.0001
2025-05-09 2025-03-31 13F CASSAVA SCIENCES CMN 14817C107 496,313 217,404 744 0.0001
2025-02-11 2024-12-31 13F CASSAVA SCIENCES CMN 14817C107 278,909 125,970 82.37 658 -85.38 0.0001
2024-11-14 2024-09-30 13F CASSAVA SCIENCES CMN 14817C107 152,939 67,694 79.41 4,501 327.76 0.0007
2024-08-13 2024-06-30 13F CASSAVA SCIENCES CMN 14817C107 85,245 32,414 61.35 1,053 -1.77 0.0002
2024-05-15 2024-03-31 13F CASSAVA SCIENCES CMN 14817C107 52,831 -108,828 -67.32 1,072 -70.56 0.0002
2024-05-14 2023-12-31 13F/A-2 CASSAVA SCIENCES CMN 14817C107 161,659 108,456 203.85 3,639 311.07 0.0007
2024-03-01 2023-12-31 13F/A-1 CASSAVA SCIENCES CMN 14817C107 161,659 108,456 3,639 0.0007
2024-02-13 2023-12-31 13F CASSAVA SCIENCES CMN 14817C107 161,659 108,456 3,639 0.0007
2024-05-15 2023-09-30 13F/A-1 CASSAVA SCIENCES CMN 14817C107 53,203 -12,317 -18.80 885 -44.89 0.0002
2023-11-14 2023-09-30 13F CASSAVA SCIENCES CMN 14817C107 53,203 -12,317 885 0.0002
2024-05-14 2023-06-30 13F/A-1 CASSAVA SCIENCES CMN 14817C107 65,520 2,007 3.16 1,607 4.90 0.0003
2023-08-15 2023-06-30 13F CASSAVA SCIENCES CMN 14817C107 65,520 2,007 1,607 0.0003
2024-05-14 2023-03-31 13F/A-1 CASSAVA SCIENCES CMN 14817C107 63,513 -95,734 -60.12 1,532 -67.45 0.0004
2023-05-11 2023-03-31 13F CASSAVA SCIENCES CMN 14817C107 63,513 -95,734 1,532 0.0003
2024-05-14 2022-12-31 13F/A-1 CASSAVA SCIENCES CMN 14817C107 159,247 82,452 107.37 4,704 156,700.00 0.0012
2023-02-13 2022-12-31 13F CASSAVA SCIENCES CMN 14817C107 159,247 82,452 4,704 0.0011
2024-05-14 2022-09-30 13F/A-1 CASSAVA SCIENCES CMN 14817C107 76,795 39,238 104.48 3 200.00 0.0008
2022-11-14 2022-09-30 13F CASSAVA SCIENCES CMN 14817C107 76,795 39,238 3,212 0.0007
2024-05-14 2022-06-30 13F/A-2 CASSAVA SCIENCES CMN 14817C107 37,557 -1,639 -4.18 1 -99.93 0.0003
2022-08-18 2022-06-30 13F/A-1 CASSAVA SCIENCES CMN 14817C107 37,557 -1,639 1,056 0.0002
2022-08-15 2022-06-30 13F CASSAVA SCIENCES CMN 14817C107 37,557 -1,639 1,056 0.0002
2022-05-16 2022-03-31 13F CASSAVA SCIENCES CMN 14817C107 39,196 -15,717 -28.62 1,456 -39.33 0.0003
2022-02-17 2021-12-31 13F/A-1 CASSAVA SCIENCES CMN 14817C107 54,913 2,956 5.69 2,400 -25.60 0.0005
2022-02-14 2021-12-31 13F CASSAVA SCIENCES CMN 14817C107 54,913 2,956 2,400 0.0001
2022-01-20 2021-09-30 13F/A-1 CASSAVA SCIENCES CMN 14817C107 51,957 -13,195 -20.25 3,226 -42.04 0.0007
2021-11-10 2021-09-30 13F CASSAVA SCIENCES CMN 14817C107 51,957 -13,195 3,226 0.0007
2021-08-13 2021-06-30 13F CASSAVA SCIENCES CMN 14817C107 65,152 16,838 34.85 5,566 156.26 0.0012
2021-05-17 2021-03-31 13F CASSAVA SCIENCES CMN 14817C107 48,314 28,866 148.43 2,172 1,533.08 0.0005
2021-02-12 2020-12-31 13F CASSAVA SCIENCES CMN 14817C107 19,448 6,905 55.05 133 -7.64 0.0000
2020-11-13 2020-09-30 13F CASSAVA SCIENCES CMN 14817C107 12,543 12,543 144 0.0000
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-11-14 2024-09-30 13F CASSAVA SCIENCES CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-13 2024-06-30 13F CASSAVA SCIENCES CMN Put 17,800 220 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.